Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
K. Sigfridsson, M. Ahlqvist, A. Carlsson & A. Fridström. (2011) Early development evaluation of AZD8081: a substrate for the NK receptors. Drug Development and Industrial Pharmacy 37:6, pages 702-713.
Read now
Read now
Jørn Herrstedt. (2004) Risk–benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting. Expert Opinion on Drug Safety 3:3, pages 231-248.
Read now
Read now
. (2001) Antidepressant therapy: new targets for drug development. Expert Opinion on Therapeutic Patents 11:11, pages 1693-1711.
Read now
Read now
Stephen C Heinrichs & Yvette Taché. (2001) Therapeutic potential of CRF receptor antagonists: a gut-brain perspective. Expert Opinion on Investigational Drugs 10:4, pages 647-659.
Read now
Read now
Articles from other publishers (29)
Dashuang Gao, Xu Gao, Fan Yang & Qingwen Wang. (2022) Neuroimmune Crosstalk in Rheumatoid Arthritis. International Journal of Molecular Sciences 23:15, pages 8158.
Crossref
Crossref
Shao-Bo Duan, Xu-Jing Gao, Hong-Yu Zhang, Cong-Cong Lu, Jiquan Zhao, Ya-Ping Han, Yuecheng Zhang & Yong-Min Liang. (2021) Palladium-catalyzed intramolecular tandem dearomatization of indoles for the synthesis of tetracyclic indolines. Arabian Journal of Chemistry 14:6, pages 103155.
Crossref
Crossref
Kalle Sigfridsson, Matti Ahlqvist, Martin Lindsjö & Stefan Paulsson. (2018) Salt formation improved the properties of a candidate drug during early formulation development. European Journal of Pharmaceutical Sciences 120, pages 162-171.
Crossref
Crossref
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
321
355
.
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
15
58
.
Rocío Recio, Empar Vengut-Climent, Bernard Mouillac, Hélène Orcel, Miguel López-Lázaro, José Manuel Calderón-Montaño, Eleuterio Álvarez, Noureddine Khiar & Inmaculada Fernández. (2017) Design, synthesis and biological studies of a library of NK1-Receptor Ligands Based on a 5-arylthiosubstituted 2-amino-4,6-diaryl-3-cyano-4 H -pyran core: Switch from antagonist to agonist effect by chemical modification. European Journal of Medicinal Chemistry 138, pages 644-660.
Crossref
Crossref
Olivier Van der Poorten, Astrid Knuhtsen, Daniel Sejer Pedersen, Steven Ballet & Dirk Tourwé. (2016) Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design. Journal of Medicinal Chemistry 59:24, pages 10865-10890.
Crossref
Crossref
Margit Pissarek. (2014) Neuropeptide Receptors in Pain Circuitries: Useful Targets for CNS Imaging with Non-Peptide Ligands Suitable for PET?. World Journal of Neuroscience 04:04, pages 353-383.
Crossref
Crossref
Georg Pongratz & Rainer H. Straub. (2012) Role of peripheral nerve fibres in acute and chronic inflammation in arthritis. Nature Reviews Rheumatology 9:2, pages 117-126.
Crossref
Crossref
Junya Shirai, Takeshi Yoshikawa, Masayuki Yamashita, Yasuharu Yamamoto, Makiko Kawamoto, Naoki Tarui, Izumi Kamo, Tadatoshi Hashimoto & Yoshinori Ikeura. (2011) Design, structure–activity relationship, and highly efficient asymmetric synthesis of 3-phenyl-4-benzylaminopiperidine derivatives as novel neurokinin-1 receptor antagonists. Bioorganic & Medicinal Chemistry 19:21, pages 6430-6446.
Crossref
Crossref
Steven Ballet, Debby Feytens, Koen Buysse, Nga N. Chung, Carole Lemieux, Suneeta Tumati, Attila Keresztes, Joost Van Duppen, Josephine Lai, Eva Varga, Frank Porreca, Peter W. Schiller, Jozef Vanden Broeck & Dirk Tourwé. (2011) Design of Novel Neurokinin 1 Receptor Antagonists Based on Conformationally Constrained Aromatic Amino Acids and Discovery of a Potent Chimeric Opioid Agonist-Neurokinin 1 Receptor Antagonist. Journal of Medicinal Chemistry 54:7, pages 2467-2476.
Crossref
Crossref
Donald J. AbrahamRandy L. Webb & Gary M. Ksander. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
515
566
.
Riccardo Patacchini & Carlo A. Maggi. 2009. Neurogenic Inflammation in Health and Disease. Neurogenic Inflammation in Health and Disease
289
320
.
Susanna Engberg, Ingela Ahlstedt, Agnes Leffler, Erik Lindström, Elin Kristensson, Arne Svensson, Ingrid Påhlman, Anders Johansson, Tomas Drmota & Bengt von Mentzer. (2007) Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors. Biochemical Pharmacology 73:2, pages 259-269.
Crossref
Crossref
Christiane Hesse, Steffen P. Luntz, Heike Siedler, Kristina Unnebrink, Gerd Mikus, Marianne de Bruijn, Edu Zondag, Michiel de Vries, Monika Seibert-Grafe & Walter E. Haefeli. (2006) Kinetics and dynamics of the peripheral neurokinin-1 receptor antagonist SLV317 in healthy individuals. British Journal of Clinical Pharmacology 61:4, pages 414-419.
Crossref
Crossref
Naïma Hanoun, Elisabeth Mocaër, Pierre-Alain Boyer, Michel Hamon & Laurence Lanfumey. (2004) Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain. Neuropharmacology 47:4, pages 515-526.
Crossref
Crossref
A.J. Nimmo, I. Cernak, D.L. Heath, X. Hu, C.J. Bennett & R. Vink. (2004) Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides 38:1, pages 40-47.
Crossref
Crossref
S. B. Mazzone & B. J. Canning. 2004. Tachykinins. Tachykinins
245
271
.
Aurelio Orjales, Ramón Mosquera, Antonio Toledo, M. Carmen Pumar, Neftalí García, Lourdes Cortizo, Luis Labeaga & Ana Innerárity. (2003) Syntheses and Binding Studies of New [(Aryl)(aryloxy)methyl]piperidine Derivatives and Related Compounds as Potential Antidepressant Drugs with High Affinity for Serotonin (5-HT) and Norepinephrine (NE) Transporters. Journal of Medicinal Chemistry 46:25, pages 5512-5532.
Crossref
Crossref
Frederik J.R Rombouts, Jeroen Van den Bossche, Suzanne M Toppet, Frans Compernolle & Georges J Hoornaert. (2003) Synthesis and conformational analysis of Substance P antagonist analogues based on a 1,7-naphthyridine scaffold. Tetrahedron 59:26, pages 4721-4731.
Crossref
Crossref
Konrad H Bleicher, Yves Wüthrich, Geo Adam, Torsten Hoffmann & Andrew J Sleight. (2002) Parallel solution- and solid-phase synthesis of spiropyrrolo-Pyrroles as novel neurokinin receptor ligands. Bioorganic & Medicinal Chemistry Letters 12:21, pages 3073-3076.
Crossref
Crossref
M G C van der Hart, B Czéh, G de Biurrun, T Michaelis, T Watanabe, O Natt, J Frahm & E Fuchs. (2002) Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Molecular Psychiatry 7:9, pages 933-941.
Crossref
Crossref
Konrad H. Bleicher, Yves Wüthrich, Maxime De Boni, Sabine Kolczewski, Torsten Hoffmann & Andrew J. Sleight. (2002) Parallel solution- and solid-Phase synthesis of spirohydantoin derivatives as neurokinin-1 receptor ligands. Bioorganic & Medicinal Chemistry Letters 12:18, pages 2519-2522.
Crossref
Crossref
A. B. Kay, E. W. Gelfand, L. J. Smith & D. Tashkin. (2002) Natural history of asthma from childhood to adulthood. Clinical & Experimental Allergy Reviews 2:4, pages 117-127.
Crossref
Crossref
Laura C Cooper, Emma J Carlson, Jose L Castro, Gary G Chicchi, Kevin Dinnell, Jerry Di Salvo, Jason M Elliott, Gregory J Hollingworth, Marc M Kurtz, Mark P Ridgill, Wayne Rycroft, Kwei-Lan Tsao & Christopher J Swain. (2002) 4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II. Bioorganic & Medicinal Chemistry Letters 12:13, pages 1759-1762.
Crossref
Crossref
Valerie A. Ashwood, Mark J. Field, David C. Horwell, Christine Julien-Larose, Russell A. Lewthwaite, Scott McCleary, Martyn C. Pritchard, Jenny Raphy & Lakhbir Singh. (2001)
Utilization of an Intramolecular Hydrogen Bond To Increase the CNS Penetration of an NK
1
Receptor Antagonist
. Journal of Medicinal Chemistry 44:14, pages 2276-2285.
Crossref
Crossref
Kevin Dinnell, Gary G Chicchi, Madhumeeta J Dhar, Jason M Elliott, Gregory J Hollingworth, Marc M Kurtz, Mark P Ridgill, Wayne Rycroft, Kwei-Lan Tsao, Angela R Williams & Christopher J Swain. (2001) 2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent. Bioorganic & Medicinal Chemistry Letters 11:9, pages 1237-1240.
Crossref
Crossref
Laura C. Cooper, Gary G. Chicchi, Kevin Dinnell, Jason M. Elliott, Gregory J. Hollingworth, Marc M. Kurtz, Karen L. Locker, Denise Morrison, Duncan E. Shaw, Kwei-Lan Tsao, Alan P. Watt, Angela R. Williams & Christopher J. Swain. (2001) 2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution. Bioorganic & Medicinal Chemistry Letters 11:9, pages 1233-1236.
Crossref
Crossref
J. Herrstedt. (2001) Potential new agents in the prophylaxis and treatment of chemotherapy-induced emesis. European Journal of Cancer 37:7, pages 823-825.
Crossref
Crossref